This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

This study has been completed.
Information provided by:
VA Office of Research and Development Identifier:
First received: July 3, 2001
Last updated: January 20, 2009
Last verified: December 2004
This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.

Condition Intervention Phase
Alzheimer's Disease Drug: estrogen Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

Resource links provided by NLM:

Further study details as provided by VA Office of Research and Development:

Study Start Date: April 1998
Estimated Study Completion Date: March 2001

Ages Eligible for Study:   50 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
  • Post menopausal women with alzheimer's disease
  • free of any major medical or neurological disease,
  • medically safe to be treated with estrogen.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00018343

United States, Washington
VA Puget Sound Health Care System
Lakewood, Washington, United States, 98493-5000
Sponsors and Collaborators
VA Office of Research and Development
OverallOfficial: Suzanne Craft, Ph.D
OverallOfficial: Laura Baker, Ph.D
OverallOfficial: Murray Raskind, M.D.
  More Information Identifier: NCT00018343     History of Changes
Other Study ID Numbers: AGCG-007-97F
Study First Received: July 3, 2001
Last Updated: January 20, 2009

Additional relevant MeSH terms:
Alzheimer Disease
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs processed this record on August 21, 2017